HPV-induced carcinogenesis of the uterine cervix is associated with reduced serum ATRA level.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractOBJECTIVE: In uterine cervical cancer, certain oncogenic HPV types are considered as key etiologic factor. But the progression of HPV associated cervical precancerous lesions depends on many other factors such as oncogenes, immune system, anti-viral factors etc. This study is therefore focused on the effect of an important dietary anti-viral factor called All Trans Retinoic Acid (ATRA) on the development of HPV associated cervical cancer as it is found higher in poor socioeconomic people. METHOD: We analyzed a total population of 130 including control subjects who have no complaints of uterine cervical lesions and the HPV-6/11, 16/18 infected cases of low grade squamous intraepithelial lesions [SIL], high grade squamous intraepithelial lesions [HSIL], and invasive cancers, for serum ATRA level. This study also focused to find out the association of serum ATRA level with the proliferation status in terms of proliferating cell nuclear antigen (PCNA) expression as it is an anti-proliferation agent and with the grades of cervical lesions, using SPSS statistical package. RESULTS: The results showed a highly significant negative association for serum ATRA level with different stages of cervical lesions (F = 3.305; P = 0.000) by one-way ANOVA and with intensity of PCNA expression (r = -0.825; P < 0.01) by Pearson's correlation test. A highly significant association was observed for the PCNA expression with the grades of cervical lesions too (F = 37.89; P = 0.000). Further, we found from our data that all the invasive cancer cases were infected with HPV-16/18 and none with HPV-6/11. Hence, we analyzed the association of serum ATRA level with HPV-16/18 infected preinvasive cases in developing invasiveness, by Fisher's Exact Test, using Graph Pad Prism as shown in Table 1. The results show an odds ratio (OR) of 36.93 and a relative risk (RR) of 4.99 with an 95% interval being 2.896 to 8.603, which is significant at the level of P = 0.0001 for the reduced [<0.6 mug/ml] serum ATRA level in developing invasive cancer in HPV-16/18 infected preinvasive cases. CONCLUSION: All these results suggest that the serum ATRA level highly influences the progression of cervical lesions to invasive cancer and can be therefore aimed as a marker for progression in combination with HPV-16/18, which helps to enhance the modalities of therapy towards cost effectiveness.
CitationGynecol. Oncol. 2006, 103 (1):113-119
DescriptionDietary modulation of cancer & cancer biomarkers Dietary item or component studied:ATRA (all-trans-retinol)Outcome studied (cancer or cancer biomarker):Cervical cancerSystem used (in vitro, animals, humans):humansStudy design (if human):case-controlStudy size (if human):20 controls, 20 low grade squamous intraepithelial lesions, 30 high grade squamous intraepithelial lesions, 60 invasive cancerTissue/biological material/sample size:10-15 sections of 10μm uterine, blood samplesMode of exposure (if in vivo):normal diet (not intervention)Impact on outcome (including dose-response):control ATRA level 0.6183+/-0.024LSIL ATRA level 0.5466+/-0.095, 9 people had HPV6, 11 had HPV11,HSIL ATRA level 0.4930+/-0.16, 6 had HPV6, 2 had HPV11,14 had HPV16, 8 had HPV18INVASIVE ATRA level 0.3097+/-0.077, 42 had HPV16, 18 had HPV18. KEYWORDS CLASSIFICATION: analysis;Adult;biomarkers of exposure & effect: field studies;biomarkers of exposure & effect: validation;biosynthesis;blood;Biotechnology;classification;complications;Cell Growth Processes;Cell Transformation,Viral;Cervical Intraepithelial Neoplasia;dietary modulation of cancer & cancer biomarkers;dietary modulation of carcinogenesis-related pathways;Female;genetics;Humans;India;Middle Aged;Neoplasm Staging;pathology;physiology;Papillomaviridae;Papillomavirus Infections;Polymerase Chain Reaction;Proliferating Cell Nuclear Antigen;Research;therapy;Tretinoin;Uterine Cervical Neoplasms;validation;virology;field studies.
- Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
- Authors: Hildesheim A, Schiffman MH, Tsukui T, Swanson CA, Lucci J 3rd, Scott DR, Glass AG, Rush BB, Lorincz AT, Corrigan A, Burk RD, Helgesen K, Houghten RA, Sherman ME, Kurman RJ, Berzofsky JA, Kramer TR
- Issue date: 1997 Oct
- CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.
- Authors: Chatterjee K, Dandara C, Hoffman M, Williamson AL
- Issue date: 2010 Jun 10
- The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix.
- Authors: Sun CA, Lai HC, Chang CC, Neih S, Yu CP, Chu TY
- Issue date: 2001 Oct
- The relative distribution of oncogenic types of human papillomavirus in benign, pre-malignant and malignant cervical biopsies. A study with human papillomavirus deoxyribonucleic acid sequence analysis.
- Authors: Andersson S, Mints M, Sällström J, Wilander E
- Issue date: 2005
- Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer.
- Authors: Branca M, Ciotti M, Giorgi C, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Syrjänen S, Favalli C, Syrjänen K, HPV-PathogenISS Study Group.
- Issue date: 2007 Feb